Recent

% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

renalman55 19 posts  |  Last Activity: Apr 26, 2016 11:02 PM Member since: Jan 3, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Cost of Production Triferic Vs Iron IV

    by mykmoney98 Apr 26, 2016 10:29 PM
    renalman55 renalman55 Apr 26, 2016 11:02 PM Flag

    Better news. The projected cost per patient using Triferic is $500.00 - $600.00 per year.

    Sentiment: Strong Buy

  • Rockwell has been talking daily with CMS about Triferic and Transitional Reimbursement plus 6%.

    This is a government program that was created in order to bring new and innovative drugs, that benefit patients, front and center and directly into the market place. If Triferic is approved for transitional reimbursement then all dialysis providers will be able to purchase the necessary Triferic for their dialysis centers from Rockwell at an established retail market price. In return CMS will reimburse these dialysis providers 106% of this cost. In other words they can use Triferic free of charge for two years and also receive another 6% incentive for doing so, Rockwell in turn gets paid a fair market price for Triferic.

    So if Company A purchases 1 million dollars of Triferic they in turn will receive one million and sixty-thousand dollars in return from CMS. In other words, they get free Triferic for two years plus an additional 6%. A great incentive to jump on board!!

    If approved this would be huge. Dialysis companies would certainly empty their shelves of toxic Iron IV product and stock them with safe and effective Triferic.

    Another large company just had a yet to be FDA approved product given transitional reimbursement plus 6%.

    Triferic meets all criteria for this reimbursement to the "T".

    Over time, CMS would benefit financially with the savings that Triferic will provide. Less nursing time, ESA sparing. A less expensive product, Healthier patients. Etc, Etc.

    Sentiment: Strong Buy

  • Reply to

    It Comes Down to A Very Simple Question?

    by renalman55 Apr 24, 2016 12:52 PM
    renalman55 renalman55 Apr 24, 2016 9:08 PM Flag

    Stay-tuned --- Triferic, Calcitriol and Citrapure will ROCK.....There is an astronomical amount of work, that is required to get an FDA product integrated into a dialysis company's system --transitional time, license agreements, product in-service and staff training, equipment upgrades, Triferic manufacturing and proper inventory, etc, etc., etc.

    If you have any doubts then repeat the words Baxter, Davita and Wanbang. Rockwell has lucrative long term agreements with all three giants. Then throw in NX Stage also!! Plus no debt and $100+ million in the bank. WOW!!

    Other than the non-sense spewed on this board, I cannot identify one negative about this company that jumps out at me. If you are looking for absolute perfection then name that company please. People on this board expect all of the above and more to be completed in a short time. It is not possible.

    Now let's talk about many more license agreements to come internationally. Probably about 30 of them. Who knows, one big company may just step in and help out??

    So my advice to all of you is put Admirable_Kerx on IGNORE. His rhetoric is useless and uniformed. It seems to me that when over 125 institutions are on board and believe in Rockwell, that speaks volumes.

    Sentiment: Strong Buy

  • RenalWeb summarized it very well.

    So if you are a dialysis patient which drug would you want during dialysis?

    1) An Iron IV drug with all of it's toxicity and bad side effects -- even the possibility of death.

    Or

    2) Triferic, which is Safe and Effective for the patient. The only water soluble Iron product on the market.

    How about your family or Physician?? What are the liabilities in continuing with Iron IV if there is a safe and more effective option -- Triferic.

    Sentiment: Strong Buy

  • renalman55 by renalman55 Apr 11, 2016 10:29 AM Flag

    Slander: utterance of false charges or misrepresentations which defame and damage another's reputation.

    Libel: A written or oral defamatory statement or misrepresentation that conveys an unjustly unfavorable impression. Attacking or defaming someone.

    Pretty obvious to 29 of us!!

    I would say that libel occurs on this board multiple times, everyday, by the same poster. It is one thing to write down your opinion but to continuously and daily libel a company who has done absolutely nothing wrong is quite another. It is hard to believe that this is allowed. Freedom of speech - yes. Freedom to libel and continually distort the truth -- NO!!!

    Sentiment: Strong Buy

  • renalman55 renalman55 Apr 11, 2016 10:22 AM Flag

    Slander: utterance of false charges or misrepresentations which defame and damage another's reputation.

    Libel: A written or oral defamatory statement or misrepresentation that conveys an unjustly unfavorable impression. Attacking or defaming someone.

    Pretty obvious to 29 of us!!

    Sentiment: Strong Buy

  • renalman55 renalman55 Apr 4, 2016 2:02 PM Flag

    So that makes it OK? -- He is just doing his job and slandering a company several times daily. Wow -- what planet are you from?? So let's excuse him for being unethical just because he is doing his job!!

  • non-stop slander of RMTI and Triferic. We as investors wonder why this is allowed to go on adnauseum. Rockwell has done nothing to this individual that would warrant such obnoxious slander and continual distortion of the truth. People like this should be held accountable for distorting the truth about Rockwell and all of its FDA approved drugs.

    Sentiment: Strong Buy

  • renalman55 renalman55 Apr 1, 2016 8:52 PM Flag

    Admirable Kerx you are on IGNORE -- Seriously we cannot hear you!!! LOL

    Sentiment: Strong Buy

  • a legal firm or both.

    It is hard for me to believe that an individual can continually slander a company with total malice and intent and not face legal backlash. This has been going on for two years and should be looked at seriously by Rockwell and Baxter and all investors.

    This guy deserves more than just a warning.

    Sentiment: Strong Buy

  • As Timing Markets says -- please do it now -- this forces the shorts out. They must cover and return these shares to the institution from which they were loaned at a price.

    Thanks Timing Markets!!! Let's put the noose around their necks and watch them squirm!!!

    Sentiment: Strong Buy

  • renalman55 renalman55 Mar 22, 2016 7:56 PM Flag

    I just did it yesterday. Just call your broker and tell him you do not want anyone to be able to short your stock -- no margin accounts. Very easy to do. Do not let these "bostords" use your RMTI stock against you by shorting.. PLEASE DO THIS!!

    Patience

    Sentiment: Strong Buy

  • renalman55 renalman55 Mar 3, 2016 7:51 AM Flag

    Plus Rockwell has over 100 million in the bank and no debt.

    This stock should be at 40.00 per share but is highly manipulated, Very sad when the patients are suffering and can really benefit from Triferic.

    The United States is the only country in the world that allows the counter- productive practice called shorting a stock. This is not investing it is scamming and lying and deceiving investors. It is gambling and nothing more. Then they get up and go to church on Sunday!! What a bunch of hypocrites. Sick low-life people!!

    Rockwell is a gem with great fundamentals. Once the CMS add-on occurs these sick untruthful shorts will have a squeeze we will all remember and it will put them in the rear view mirror forever.

    Please -- patience. The patients really deserve the wonderful benefits of Triferic. WANBANG of China thinks so!!

    Sentiment: Strong Buy

  • renalman55 renalman55 Mar 2, 2016 7:54 PM Flag

    I am here and still a long time Rockwell investor. When you think about how far this company has come it is really amazing:

    1) Phase one, two and three and AdCom. Triferic passed with flying colors.Safe and effective and lowers ESAs.

    2) 160 million spent and FDA Approval of Triferic.

    3) Partnerships with NxStage, Davita, Baxter and now WanBang of China. More license agreements to come.

    4) Rockwell has filed an IND to Investigate Triferic for Rare Orphan Disease Iron-Refractory, Iron- Deficiency and Anemia.

    5) Rockwell purchased Calcitriol and now waits for the manufacturing of enough product for launch.

    6) Rockwel hasl been talking to CMS often for designated special add-on reimbursement (106%) for new and innovative drugs that benefit patients. Triferic certainly qualifies for this designation as patients are now clearly benefiting from this new and innovative drug. If this designation is given then if Company A purchases $10,000.00 of Triferic they would be reimbursed $10,600.00 by CMS. As a result, it is no cost to them initially, until they use it for a designated period of time. A no brainer as it is safe and effective. Basically a win-win deal. No gamble by the provider and great saving for CMS in the long run.

    I really do not understand what all the fuss is about. The trouble is that many of these supposed experts have never seen a drug taken from infancy to FDA approval to the market and their expectations and timelines are not realistic. Let me tell you this if WanBang wants the rights to Triferic then you have a real winner.

    Patience -- Rob is a winner and continues to work relentlessly. Naysayers are full of it!!!

    Sentiment: Strong Buy

  • Reply to

    Announcement Monday Morning????

    by rivercrest1996 Feb 27, 2016 5:09 PM
    renalman55 renalman55 Feb 27, 2016 7:08 PM Flag

    I agree. The timing is perfect for Rockwell to send the shorts to the exits for good. Then the sky is the limit.

    If you were on dialysis which product would you want running through you body? Iron IV with new warning labels and all kinds of toxic side effects OR Triferic which is proven to be safe and effective and even lowers the amount of ESAs to be used.

    Physicians would have to be very leary of using Iron IV when there is a much safer drug that is FDA approved and now on the market -- TRIFERIC.

    Looking forward to Monday afternoon.

    Sentiment: Strong Buy

  • US China
    Population 319 Million 1.3 Billion 4.1X more people

    Est'd # patients w/ Chronic Kidney Disease Requiring Treatment 28 Million 120 Million 4.3X more have disease

    Major causes Diabetes, obesity, hypertension, aging Same

    Est'd # of patients who need dialysis but lack access to care None 2 Million

    Est'd # on dialysis 506,000 300,000

    Est'd annual dialysis growth rate to 2020 4-5% 15-20%

    # of people waiting for diallysis & kidney transplant 100,791 1,700,000 17X more

    Avg # of kidney transplants/yr 17,107 5-6,000

    Sentiment: Strong Buy

  • other business partners to be named soon -- an excellent resume for Rockwell.

    Plus 114 million in the bank and no debt......WOW!!! Impressive!

    This is just the beginning..........get ready for a ride of a lifetime!!!!

    Sentiment: Strong Buy

  • One morning we will wake up and ............... I told you so!!

    This is just the start ---- BANG!!!!

    Sentiment: Strong Buy

  • Reply to

    TRIFERIC SOLVES FDA ISSUES w/ Current IV IRON

    by do_your_dd Jan 25, 2016 7:40 PM
    renalman55 renalman55 Feb 15, 2016 9:03 AM Flag

    Which one would you want during dialysis?? Iron IV which is toxic with serious side effects OR Triferic which is SAFE and EFFECTIVE!!

    Sentiment: Strong Buy

RMTI
9.25-0.51(-5.23%)Apr 29 4:00 PMEDT